CANbridge Pharmaceuticals Inc. (1228.HK)

HKD 0.16

(0.65%)

Gross Profit Summary of CANbridge Pharmaceuticals Inc.

  • CANbridge Pharmaceuticals Inc.'s latest annual gross profit in 2023 was 64.16 Million CNY , up 31.23% from previous year.
  • CANbridge Pharmaceuticals Inc.'s latest quarterly gross profit in 2024 Q2 was 14.71 Million CNY , down 0.0% from previous quarter.
  • CANbridge Pharmaceuticals Inc. reported a annual gross profit of 48.89 Million CNY in annual gross profit 2022, up 160.41% from previous year.
  • CANbridge Pharmaceuticals Inc. reported a annual gross profit of 18.77 Million CNY in annual gross profit 2021, up 172.99% from previous year.
  • CANbridge Pharmaceuticals Inc. reported a quarterly gross profit of 14.71 Million CNY for 2024 Q1, down -21.47% from previous quarter.
  • CANbridge Pharmaceuticals Inc. reported a quarterly gross profit of 18.74 Million HKD for 2023 Q3, up 40.52% from previous quarter.

Annual Gross Profit Chart of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Gross Profit of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 64.16 Million CNY 31.23%
2022 48.89 Million CNY 160.41%
2021 18.77 Million CNY 172.99%
2020 6.87 Million CNY 612.75%
2019 965 Thousand CNY 0.0%

Peer Gross Profit Comparison of CANbridge Pharmaceuticals Inc.

Name Gross Profit Gross Profit Difference
Uni-Bio Science Group Limited 392.81 Million HKD 83.666%
CK Life Sciences Int'l., (Holdings) Inc. 947.7 Million HKD 93.23%